Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01226472 · ClinicalTrials.gov registry record · Phase 2
Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
A Phase 2 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01226472: Completed Phase 2 study, sponsored by Kyowa Kirin Co..
NCT01226472 is a Phase 2 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01226472, a Phase 2 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study will enroll subjects with either Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma(CTCL),including mycosis fungoides (MF) and Sezary Syndrome (SS), who have relapsed after achieving a complete response in study, KW-0761-001.
Interventions
- BIOLOGICAL KW-0761
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-09 |
| Phase | Phase 2 |
What the finished NCT01226472 record still lists
NCT01226472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which KW-0761 is the first listed.
NCT01226472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01226472 about?
NCT01226472 is a clinical study titled "Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001". This study will enroll subjects with either Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma(CTCL),including mycosis fungoides (MF) and Sezary Syndrome (SS), who have relapsed after achieving a complete response in study, KW-0761-001.
What is the current status of trial NCT01226472?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2010-08. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01226472?
The interventions under investigation include: KW-0761 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01226472?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01226472's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia